AZ India Unit Votes To Delist From Local Stock Exchanges
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca Pharma India's board voted in favor of taking itself off the India stock exchanges as requested by the parent, UK-headquartered AstraZeneca Pharmaceutical, after it acquired 75% of the India subsidiary.